Searched for
MSD INDIA
HPV vaccination drive reaches 50 lakh girls in three monthsIndia's free Human Papillomavirus vaccination drive is making significant progress. Nearly 50 lakh doses of the cervical cancer vaccine hav...- Aurobindo Pharma enters biologics contract manufacturing with Rs 1,200-crore Telangana facilityAurobindo Pharma has launched TheraNym, a major biologics manufacturing plant in Telangana. This facility will produce biologic medicines f...
- Chinese medicines bring relief to India’s cancer patientsIndia’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...
- MSD India ropes in Madhuri Dixit for cervical cancer awareness driveUS pharma major MSD has partnered with Bollywood actor Madhuri Dixit for a nationwide cervical cancer awareness program in India. The initi...
- Sun Pharma shares rally 9% in two days after $12-bn Organon deal. Here's what Morgan Stanley, other brokerages saySun Pharmaceutical Industries' shares surged nearly 9% after announcing the $11.75 billion acquisition of Organon & Co., a global leader in...
- Sun Pharma shares jump over 9% after firm announces $12 billion Organon acquisitionSun Pharmaceutical Industries' shares surged after announcing the $11.75 billion acquisition of US-based Organon & Co., a global leader in ...
- ET Exclusive | Sun Pharma set to acquire Organon for $12.5 bn, its biggest till dateUS company’s board meeting is happening this weekend to finalise decision; an announcement is imminent later tonight or by Monday. Mumbai H...
- Sun Pharma looks to outshine rival bids with $13 billion Organon offerSun Pharmaceutical is making its biggest move yet with a $13 billion offer for Organon & Co. This ambitious bid aims to transform the India...
- Abbott, MSD Pharmaceuticals ink distribution pact for oral anti-diabetic medicines in IndiaAbbott and MSD Pharmaceuticals have partnered to distribute oral anti-diabetic medicines in India. Abbott will distribute MSD's sitagliptin...
- MSD Pharma, Delhi Capitals partner to create awareness about cervical cancer preventionMSD Pharmaceuticals and Delhi Capitals have partnered to raise cervical cancer prevention awareness in India. The women's T20 team will dis...
- Merck says no safety concerns observed in molnupiravir phase-3 trial, shared relevant data with DCGIMerck Sharp & Dohme (MSD) on Friday said its COVID antiviral molnupiravir has cut the risk of hospitalization or death in Phase 3 clinical ...
- MSD to sign licensing pacts with 5 Indian drug firms for oral drug candidate for COVID-19MSD has decided to enter into non-exclusive voluntary licensing agreements for molnupiravir with five established Indian generic manufactur...
- Merck's Indian unit MSD may sell primary care drugs to focus on core brandsA sizeable part of the divestiture is from the primary care segment with a few Indian drug makers showing interest. Valuation is, however, ...
- MSD launches medical, healthcare website called 'Univadis'Univadis is an online resource for healthcare professionals launched in 40 countries, available in 17 languages, with 20 mn registered user...
- Lupin to market MSD's pneumonia prevention vaccine in IndiaAs part of the agreement promote and distribute MSD's 23-valent Pneumococcal Polysaccharide Vaccine under a different brand name in the cou...
- MSD India to invest $10 million to reduce maternal mortalityMSD for Mothers, drug firm would partner three non-governmental organisations across three states in India- Rajasthan, Jharkhand and Uttar ...
- MSD India eyes more partnerships to widen product presenceDrug firm MSD India today said it is looking for commercial partnerships, such as the one that it has with Sun Pharma.
- Relocation triggers exits at Merck armAround 50 executives quit MSD, the Indian arm of Merck & Co, in the past few months — most opted out due to the company’s decision to reloc...
- Merck arm to sell cheap diabetes drugThis is perhaps one of the few instances where a drug is cheaper in India, as against its price in other developed markets. (Januvia is pri...
- Merck subsidiary plans to launch patented drugsMerck Sharp & Dohme (MSD) Pharmaceuticals is betting big on India, an emerging market for its patented and first research-based vaccines an...
Load More
